Rettie AE - Search Results

1

In vitro methods for assessing human hepatic drug metabolism: their use in drug development.

Wrighton SA, Vandenbranden M, Stevens JC, Shipley LA, Ring BJ, Rettie AE, Cashman JR. Wrighton SA, et al. Among authors: rettie ae. Drug Metab Rev. 1993;25(4):453-84. doi: 10.3109/03602539308993982. Drug Metab Rev. 1993. PMID: 8313838 Review. No abstract available.

2

Relationships between the levels of cytochrome P4502C9 and its prototypic catalytic activities in human liver microsomes.

Hall SD, Hamman MA, Rettie AE, Wienkers LC, Trager WF, Vandenbranden M, Wrighton SA. Hall SD, et al. Among authors: rettie ae. Drug Metab Dispos. 1994 Nov-Dec;22(6):975-8. Drug Metab Dispos. 1994. PMID: 7895619 No abstract available.

3

Stereoselective sulfoxidation of sulindac sulfide by flavin-containing monooxygenases. Comparison of human liver and kidney microsomes and mammalian enzymes.

Hamman MA, Haehner-Daniels BD, Wrighton SA, Rettie AE, Hall SD. Hamman MA, et al. Among authors: rettie ae. Biochem Pharmacol. 2000 Jul 1;60(1):7-17. doi: 10.1016/s0006-2952(00)00301-4. Biochem Pharmacol. 2000. PMID: 10807940

4

Inactivation of multiple hepatic cytochrome P-450 isozymes in rats by allylisopropylacetamide: mechanistic implications.

Bornheim LM, Underwood MC, Caldera P, Rettie AE, Trager WF, Wrighton SA, Correia MA. Bornheim LM, et al. Among authors: rettie ae. Mol Pharmacol. 1987 Aug;32(1):299-308. Mol Pharmacol. 1987. PMID: 3302670

5

Differential apoprotein loss of rat liver cytochromes P450 after their inactivation by 3,5-dicarbethoxy-2,6-dimethyl-4-ethyl-1,4-dihydropyridine: a case for distinct proteolytic mechanisms?

Correia MA, Yao K, Wrighton SA, Waxman DJ, Rettie AE. Correia MA, et al. Among authors: rettie ae. Arch Biochem Biophys. 1992 May 1;294(2):493-503. doi: 10.1016/0003-9861(92)90716-a. Arch Biochem Biophys. 1992. PMID: 1567205

6

Degradation of rat hepatic cytochrome P-450 heme by 3,5-dicarbethoxy-2,6-dimethyl-4-ethyl-1,4-dihydropyridine to irreversibly bound protein adducts.

Correia MA, Decker C, Sugiyama K, Caldera P, Bornheim L, Wrighton SA, Rettie AE, Trager WF. Correia MA, et al. Among authors: rettie ae. Arch Biochem Biophys. 1987 Nov 1;258(2):436-51. doi: 10.1016/0003-9861(87)90365-1. Arch Biochem Biophys. 1987. PMID: 3674884

7

Developmental expression of human hepatic CYP2C9 and CYP2C19.

Koukouritaki SB, Manro JR, Marsh SA, Stevens JC, Rettie AE, McCarver DG, Hines RN. Koukouritaki SB, et al. Among authors: rettie ae. J Pharmacol Exp Ther. 2004 Mar;308(3):965-74. doi: 10.1124/jpet.103.060137. Epub 2003 Nov 21. J Pharmacol Exp Ther. 2004. PMID: 14634042

8

Role of biotransformation in drug-induced toxicity: influence of intra- and inter-species differences in drug metabolism.

Baillie TA, Rettie AE. Baillie TA, et al. Among authors: rettie ae. Drug Metab Pharmacokinet. 2011;26(1):15-29. doi: 10.2133/dmpk.dmpk-10-rv-089. Epub 2010 Oct 22. Drug Metab Pharmacokinet. 2011. PMID: 20978360 Free PMC article. Review.

9

Ocular cytochrome P450s and transporters: roles in disease and endobiotic and xenobiotic disposition.

Nakano M, Lockhart CM, Kelly EJ, Rettie AE. Nakano M, et al. Among authors: rettie ae. Drug Metab Rev. 2014 Aug;46(3):247-60. doi: 10.3109/03602532.2014.921190. Epub 2014 May 26. Drug Metab Rev. 2014. PMID: 24856391 Free PMC article. Review.

10

Stereoselective sulfoxidation by human flavin-containing monooxygenase. Evidence for catalytic diversity between hepatic, renal, and fetal forms.

Sadeque AJ, Eddy AC, Meier GP, Rettie AE. Sadeque AJ, et al. Among authors: rettie ae. Drug Metab Dispos. 1992 Nov-Dec;20(6):832-9. Drug Metab Dispos. 1992. PMID: 1362935

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

225 results

Search Page